110 related articles for article (PubMed ID: 15026036)
1. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
[TBL] [Abstract][Full Text] [Related]
2. Core exploration in optimization of chemokine receptor CCR4 antagonists.
Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
[TBL] [Abstract][Full Text] [Related]
3. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.
Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
Bioorg Med Chem; 2008 Jul; 16(14):7021-32. PubMed ID: 18539035
[TBL] [Abstract][Full Text] [Related]
5. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
[TBL] [Abstract][Full Text] [Related]
6. Identification of chemokine receptor CCR4 antagonist.
Purandare AV; Gao A; Wan H; Somerville J; Burke C; Seachord C; Vaccaro W; Wityak J; Poss MA
Bioorg Med Chem Lett; 2005 May; 15(10):2669-72. PubMed ID: 15863339
[TBL] [Abstract][Full Text] [Related]
7. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
[TBL] [Abstract][Full Text] [Related]
8. Optimization of CCR4 antagonists: side-chain exploration.
Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
[TBL] [Abstract][Full Text] [Related]
9. Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
Wang X; Xu F; Xu Q; Mahmud H; Houze J; Zhu L; Akerman M; Tonn G; Tang L; McMaster BE; Dairaghi DJ; Schall TJ; Collins TL; Medina JC
Bioorg Med Chem Lett; 2006 May; 16(10):2800-3. PubMed ID: 16497499
[TBL] [Abstract][Full Text] [Related]
10. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
[TBL] [Abstract][Full Text] [Related]
11. The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.
Ting PC; Lee JF; Wu J; Umland SP; Aslanian R; Cao J; Dong Y; Garlisi CG; Gilbert EJ; Huang Y; Jakway J; Kelly J; Liu Z; McCombie S; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Mar; 15(5):1375-8. PubMed ID: 15713390
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.
Varnes JG; Gardner DS; Santella JB; Duncia JV; Estrella M; Watson PS; Clark CM; Ko SS; Welch P; Covington M; Stowell N; Wadman E; Davies P; Solomon K; Newton RC; Trainor GL; Decicco CP; Wacker DA
Bioorg Med Chem Lett; 2004 Apr; 14(7):1645-9. PubMed ID: 15026042
[TBL] [Abstract][Full Text] [Related]
13. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
[TBL] [Abstract][Full Text] [Related]
14. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.
Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Sudo M; Tsutsumi T; Endo N; Muroga Y; Hada T; Tanaka H; Morita T; Greene J; Barnum D; Saunders J; Kato Y; Myers PL; Tarby CM
Bioorg Med Chem Lett; 2004 Nov; 14(21):5413-6. PubMed ID: 15454236
[TBL] [Abstract][Full Text] [Related]
15. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
16. Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.
Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hattori K; Miyazaki T; Ogino S; Orita M; Matsumoto Y; Takeuchi M; Ohta M
Bioorg Med Chem; 2008 Sep; 16(17):7968-74. PubMed ID: 18694645
[TBL] [Abstract][Full Text] [Related]
17. Diaryl substituted pyrazoles as potent CCR2 receptor antagonists.
Pinkerton AB; Huang D; Cube RV; Hutchinson JH; Struthers M; Ayala JM; Vicario PP; Patel SR; Wisniewski T; DeMartino JA; Vernier JM
Bioorg Med Chem Lett; 2007 Feb; 17(3):807-13. PubMed ID: 17088058
[TBL] [Abstract][Full Text] [Related]
18. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
[TBL] [Abstract][Full Text] [Related]
19. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
20. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
